PharmaSafe and PharmaTox leader Hedvig Nordeng co-authored the new text book “Drug Utilization Research: Methods and Applications”.
News - Page 6
PharmaSafe group leader was in charge of one teaching session at the ENTIS-ISoP-NFIF Training Course: «Risk assessment of drug use during pregnancy and lactation»
Dr. Jacqueline Cohen, Postdoc at Harvard T.H. Chan School of Public Health spent six weeks at the PharmaSafe group. Her research interests have now been featured on titan.uio.no.
According to the new Norwegian popular science magazine Aftenposten Vitenskap (Science), PharmaTox leader Hedvig Nordeng is one of 25 Norwegian scientists you should have heard of.
The PharmaSafe group and the PharmaSafe Research Initiative are proud to present a guest lecture by Dr. Jacqueline Cohen, Postdoc at Harvard T.H. Chan School of Public Health.
Multiple positions are available within the PharmaTox Strategic Research Initiative.
The PharmaSafe group has been granted 675,000 NOK per year for three years from the Norwegian Women's Public Health Association to finance one PhD student.
As part of The Forum for causal interference, PharmaSafe's Mollie Wood will be giving a lecture with the title: "Exposure misclassification and propensity score methods: a simulation study"
Research have found that children of pregnant women who made prolonged use of the antipyretic and analgesic drug paracetamol may have an increased risk of developing ADHD. But where is the limit of what is "prolonged"?
The PharmaTox Strategic Research Initiative was established 1 January 2015 as a partnership between FAI, MI, IFI and IBV at the Faculty of Mathematics and Natural Sciences. October 16th 2015 all participants at the different departments were invited to come together and celebrate at PharmaTox's official kick-off. The goal of the day was to let the members of PharmaTox get to know each other and provide an overview on how the different departments contribute to the initiative.
A short interview with PharmaTox's new postdoctoral fellow Mollie Wood after winning the 2015 SPER Student Prize Paper Award.
We are pleased to welcome Gema Escribano Serrano into PharmaTox Strategic Research environment at the MN-faculty!
We are very happy to welcome Mollie Wood and Emil Aas Stoltenberg into the PharmaTox Strategic Research environment at the MN-faculty!
Three-year-old siblings exposed to antidepressants in pregnancy show increased anxiety symptoms compared to their unexposed siblings.
Pharmacological treatment of migraine during pregnancy and breastfeeding is possible. This is reported in a new review by researchers from Pharmatox. The paper was recently published in Nature Reviews Neurology.
Gathering of The Research Council of Norway’s Young Research Talents Ragnhild Eskeland and Eivind Ystrøm, two PharmaTox members. We are proud!
Position as PhD Research fellow in biostatistics is available at the Dept. of Mathematics, Faculty of Mathematics and Natural Sciences, University of Oslo. The fellowship is part of the PharmaTox Strategic Research Initiative.
Professor Hedvig Nordeng has receieved an ERC Starting Grant for the project entitled "Effects of Medication Use in Pregnancy on Infant Neurodevelopment (DrugsInPregnancy)."
The project will run for five years and has been awarded 1.5 Million Euro.
Silje Bratseth is going to study whether drugs that are used by pregnant women may impact on neuronal development.